Can an old drug give cancer patients a new lease on life?

NCT ID NCT06557668

Recruiting now Disease control Sponsor: Taichung Veterans General Hospital Source: ClinicalTrials.gov ↗

Summary

This study looks back at the medical records of 250 colorectal cancer patients to see if adding an immune-boosting drug (Astragalus Polysaccharide) to their standard cancer treatments helped them live longer or better. The goal is to understand if this combination offers a benefit, so doctors can make better treatment recommendations. The study is not testing a new cure, but rather evaluating a possible way to improve control of the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Chung-Shan Medical University Hospital
NOT_YET_RECRUITING

Taichung, Taiwan
Taichung Veterans General Hospital
RECRUITING

Taichung, Taiwan

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER